Krystal Biotech (NASDAQ:KRYS) said it has generated positive interim clinical results for its inhaled cystic fibrosis (CF) ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutationsKB407 transduction confirmed in all ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...

A live webcast of the presentation will be available under the “Events” page within the Investors section of Sionna’s website ...

Sionna Therapeutics raised about $191 million in its initial public offering last February. Since then it's made progress with experimental treatments for cystic fibrosis. In June, the company ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

Researchers at the Indian Institute of Science (IISc), with collaborators from the Institute of Mathematical Sciences (IMSc), ...

Cholera, a severe bacterial infection that causes diarrhea and kills if untreated, can be defeated with a diet high in ...

Northwestern University scientists have uncovered a hidden molecular "control switch" inside a protein that helps the body ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant Pau (IR Sant Pau), has achieved what for decades had been an elusive goal: ...